Instituto de Cardiologia de Corrientes Juana Francisca Cabral

Corrientes W3400AMZ

1 studies enrolling now · 6 studies all time

What they study most

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Coronary Heart Disease (CHD), Diabetic Nephropathy, Pulmonary Arterial Hypertension, Pulmonary Hypertension

Studies at this site

• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed